U.S. Health Officials Accuse AstraZeneca of Misrepresenting Efficacy Data
An independent trial review board says AstraZeneca may have included outdated information about its clinical trial results in a press release.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
